Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Iovance Biotherapeutics (IOVA) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • Iovance Biotherapeutics' Interest & Investment Income fell 6896.38% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.1 million, marking a year-over-year increase of 3131.15%. This contributed to the annual value of $20.3 million for FY2024, which is 5543.2% up from last year.
  • Latest data reveals that Iovance Biotherapeutics reported Interest & Investment Income of $1.2 million as of Q3 2025, which was down 6896.38% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Iovance Biotherapeutics' Interest & Investment Income registered a high of $9.6 million during Q4 2024, and its lowest value of $1.2 million during Q3 2025.
  • Over the past 3 years, Iovance Biotherapeutics' median Interest & Investment Income value was $3.4 million (recorded in 2024), while the average stood at $3.8 million.
  • As far as peak fluctuations go, Iovance Biotherapeutics' Interest & Investment Income skyrocketed by 20708.79% in 2024, and later crashed by 6896.38% in 2025.
  • Iovance Biotherapeutics' Interest & Investment Income (Quarter) stood at $3.1 million in 2023, then skyrocketed by 207.09% to $9.6 million in 2024, then plummeted by 87.02% to $1.2 million in 2025.
  • Its Interest & Investment Income was $1.2 million in Q3 2025, compared to $4.1 million in Q2 2025 and $3.2 million in Q1 2025.